SCHEMBL4669117

SCHEMBL4669117

O=CCN(CCC1CCCCC1)C(=O)O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM5A P29375 3/20 0.39
PHF8 Q9UPP1 3/20 0.39
KDM2A Q9Y2K7 3/20 0.39
KDM4C Q9H3R0 2/20 0.39
KDM4A O75164 1/20 0.39
ALOX5 P09917 2/20 0.38
HPGD P15428 2/20 0.36
LMNA P02545 1/20 0.35
CASR P41180 1/20 0.35
EPHX1 P07099 2/20 0.34
SIGMAR1 Q99720 1/20 0.34
KMT2A Q03164 1/20 0.34
ADH1B P00325 1/20 0.33
ADH1C P00326 1/20 0.33
ADH1A P07327 1/20 0.33
ADH4 P08319 1/20 0.33
ADH7 P40394 1/20 0.33
EPHX2 P34913 1/20 0.33
SLC1A3 P43003 1/20 0.33
SLC1A2 P43004 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4668913 0.81 ALOX5 (0.48) ALOX5HPGDLMNAEPHX1KMT2A
SCHEMBL3653256 0.81 KDM5A (0.41) KDM5APHF8KDM2AKDM4CKDM4A
SCHEMBL4667724 0.80 KDM5A (0.40) KDM5APHF8KDM2AKDM4CKDM4A
SCHEMBL30123594 0.78 EPHX1 (0.37) KDM5APHF8KDM2AKDM4CKDM4A
SCHEMBL11594646 0.72 KDM5A (0.41) KDM5APHF8KDM2AKDM4CKDM4A
SCHEMBL10323213 0.72 KDM5A (0.41) KDM5APHF8KDM2AKDM4CKDM4A
SCHEMBL2468579 0.71 LMNA (0.32) LMNA
SCHEMBL4669071 0.70 KDM5A (0.44) KDM5APHF8KDM2AKDM4CKDM4A
SCHEMBL10323234 0.69 KDM5A (0.40) KDM5APHF8KDM2AKDM4CKDM4A
SCHEMBL29340445 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1899353-A1 THIENOPYRIMIDINES FOR PHARMACEUTICAL COMPOSITIONS DeveloGen Aktiengesellschaft (DE) 2008-03-19 EP claimed
WO-2007059905-A9 THIENOPYRIMIDINES TREATING INFLAMMATORY DISEASES DEVELOGEN AG (DE) 2007-11-01 WO claimed
WO-2007059905-A2 THIENOPYRIMIDINES TREATING INFLAMMATORY DISEASES DEVELOGEN AKTIENGESELLSCHAFT (DE) 2007-05-31 WO claimed
WO-2006136402-A1 THIENOPYRIMIDINES FOR PHARMACEUTICAL COMPOSITIONS DEVELOGEN AKTIENGESELLSCHAFT (DE) 2006-12-28 WO claimed
EP-2001876-A2 8-AZABICYCLOÝ3.2.1¨OCTANE COMPOUNDS AS MU OPIOID RECEPTOR ANTAGONISTS Theravance, Inc. (US) 2008-12-17 EP disclosed
WO-2007059905-A9 THIENOPYRIMIDINES TREATING INFLAMMATORY DISEASES DEVELOGEN AG (DE) 2007-11-01 WO disclosed
WO-2007103187-A2 8-AZABICYCLO[3.2.1]OCTANE COMPOUNDS AS MU OPIOID RECEPTOR ANTAGONISTS THERAVANCE, INC. (US) 2007-09-13 WO disclosed
WO-2007059905-A2 THIENOPYRIMIDINES TREATING INFLAMMATORY DISEASES DEVELOGEN AKTIENGESELLSCHAFT (DE) 2007-05-31 WO disclosed